Provided by Tiger Fintech (Singapore) Pte. Ltd.

Y-mAbs Therapeutics, Inc.

4.25
-0.1600-3.63%
Post-market: 4.00-0.2498-5.88%19:15 EDT
Volume:178.87K
Turnover:774.81K
Market Cap:192.18M
PE:-6.34
High:4.60
Open:4.39
Low:4.24
Close:4.41
Loading ...
Apr 29, 2025

[Rev.]Annual Report

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Mar 07, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 07, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 07, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 07, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 05, 2025

Major Issues Report

Form 8-K - Current report
Mar 04, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 04, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 04, 2025

Major Issues Report

Form 8-K - Current report
Jan 13, 2025

Major Issues Report

Form 8-K - Current report
Jan 10, 2025

Major Issues Report

Form 8-K - Current report
Nov 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 08, 2024

Major Issues Report

Form 8-K - Current report
Nov 04, 2024

Major Issues Report

Form 8-K - Current report
Sep 27, 2024

Correspondence

Form CORRESP - Correspondence
Sep 20, 2024

Major Issues Report

Form 8-K - Current report
Sep 17, 2024

Major Issues Report

Form 8-K - Current report
Sep 13, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities